BFM
CALA

Boothbay Fund Management’s Calithera Biosciences, Inc CALA Stock Holding History

Boothbay Fund Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-955
Closed -$40K – 2344
2021
Q2 		$40K Buy
+955
New +$42K ﹤0.01% 1776
2020
Q4 		– Sell
-980
Closed -$68K – 1503
2020
Q3 		$68K Buy
980
+100
+11% +$8.73K ﹤0.01% 995
2020
Q2 		$93K Sell
880
-100
-10% -$11.9K 0.01% 884
2020
Q1 		$87K Buy
+980
New +$117K 0.01% 740

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's CALA Position: Q3 2021 in Review

Boothbay Fund Management sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 955 shares — an estimated $40K sold.

Boothbay Fund Management first reported a position in CALA in Q1 2020 and held it in 4 quarters. The position peaked at $93K in Q2 2020. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Boothbay Fund Management reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 955 Calithera Biosciences, Inc shares in Q3 2021, an estimated $40K.
  • Boothbay Fund Management first reported a position in Calithera Biosciences, Inc in Q1 2020 and held it in 4 quarters.
  • Boothbay Fund Management's Calithera Biosciences, Inc position peaked at $93K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.